中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2013年
4期
674-675
,共2页
周经霞%苏庆杰%曾超胜%吴海荣
週經霞%囌慶傑%曾超勝%吳海榮
주경하%소경걸%증초성%오해영
丹参川芎嗪注射液%常规治疗%脑卒中%疗效%血液流变
丹參川芎嗪註射液%常規治療%腦卒中%療效%血液流變
단삼천궁진주사액%상규치료%뇌졸중%료효%혈액류변
Danshen Chuanxiongqin Injection%Conventional Treatment%Cerebral Apoplexy%Curative Effect%Blood Rheology
目的:探讨丹参川芎嗪注射液联合常规治疗对脑卒中患者血液流变学的影响.方法:将我院2010年12月至2011年5月收治的100例脑卒中的患者按照治疗方法的不同分为治疗组和对照组,对照组采用脑卒中常规疗法,治疗组在对照组的基础上采用丹参注射液治疗,比较两组患者的治疗效果及血液流变学的变化.结果:两组患者均无恶化和死亡病例出现,治疗组的总有效率为72.0%显著高于对照组的52.0%(P<0.05).观察组的全血高切粘度、全血低切粘度以及红细胞压积改善显著优于对照组(P<0.05).结论:丹参川芎嗪注射液联合常规治疗能显著提高脑卒中患者的治疗效果,可能与其减低患者的血液粘度,增加脑部血液供应有关.
目的:探討丹參川芎嗪註射液聯閤常規治療對腦卒中患者血液流變學的影響.方法:將我院2010年12月至2011年5月收治的100例腦卒中的患者按照治療方法的不同分為治療組和對照組,對照組採用腦卒中常規療法,治療組在對照組的基礎上採用丹參註射液治療,比較兩組患者的治療效果及血液流變學的變化.結果:兩組患者均無噁化和死亡病例齣現,治療組的總有效率為72.0%顯著高于對照組的52.0%(P<0.05).觀察組的全血高切粘度、全血低切粘度以及紅細胞壓積改善顯著優于對照組(P<0.05).結論:丹參川芎嗪註射液聯閤常規治療能顯著提高腦卒中患者的治療效果,可能與其減低患者的血液粘度,增加腦部血液供應有關.
목적:탐토단삼천궁진주사액연합상규치료대뇌졸중환자혈액류변학적영향.방법:장아원2010년12월지2011년5월수치적100례뇌졸중적환자안조치료방법적불동분위치료조화대조조,대조조채용뇌졸중상규요법,치료조재대조조적기출상채용단삼주사액치료,비교량조환자적치료효과급혈액류변학적변화.결과:량조환자균무악화화사망병례출현,치료조적총유효솔위72.0%현저고우대조조적52.0%(P<0.05).관찰조적전혈고절점도、전혈저절점도이급홍세포압적개선현저우우대조조(P<0.05).결론:단삼천궁진주사액연합상규치료능현저제고뇌졸중환자적치료효과,가능여기감저환자적혈액점도,증가뇌부혈액공응유관.
@@@@Objective:To study the effects of Danshen Chuanxiongqin injection combined with conventional treatment in patients with cerebral apoplexy and blood rheology. Methods: 100 cases of cerebral apoplexy patients in our courtyard from 2010 December to 2011 May were divided into the treat group and the control group according to different treatments. The control group were used the conventional stroke therapy, and the treatment group were used the treatment of Danshen Chuanxiongqin injection. Comparing the two groups of the treatment and changes of blood rheology. Results:There were no deterionration and death cases in two groups, and the total effective rate in the treatment group was 72% better than the control group 52% (P<0.05). The observation group in the whole blood viscosity, blood viscosity and hematocrit improves significantly better than the control group (P<0.05). Conclusion: Danshen Chuanxiongqin injection combined with routine therapy can significantly improve the treatment of stroke patients, which may be about to reduce the risk of patients blood viscosity and increase the blood supply to the brain.